--- title: "Profil: Your partner for clinical development" description: Profil has world-class expertise in all methods required for the clinical development of novel solutions for diabetes, obesity. --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com?hsLang=en-us) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Clinical Development at Profil](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x400px_Clinical_development.jpg?width=1077&height=400&name=Header_1077x400px_Clinical_development.jpg) # Clinical Development Your partner for clinical development. ## Diabetes drugs in clinical trials Profil supports the full range of early-phase trials required for the clinical development of novel solutions for diabetes, prediabetes and obesity. Our core expertise covers all of the essential methods for diabetes medication clinical trials, including glucose clamp studies, pharmacokinetic and pharmacodynamic studies, safety and tolerability studies, and bioequivalence or bridging studies. With hundreds of studies in many drug discovery projects to our name, we have the experience and knowledge to be the perfect partner for clinical trials. Our clinical development consulting team will aid you in developing the study design that generates the necessary data to achieve critical goals, such as product registration in the EU or North America or out-licensing or selling of an IP. Read on to discover more about the specialized services we offer in the clinical development of diabetes treatments. ![Clinical-Development_Content1.png](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/content-bilder/Clinical_Development/Clinical-Development_Content1.png?width=220&name=Clinical-Development_Content1.png "Clinical-Development_Content1.png") [Bioequivalence and biosimilars ``` Read more ``` Let Profil support you with your clinical trials on insulin biosimilars. ](https://www.profil.com/services/biosimilar?hsLang=en-us) [Pharmacodynamics ``` Read more ``` Consult with Profil Germany about your pharmacodynamic study design. ](https://www.profil.com/services/pharmacodynamics?hsLang=en-us) [Pharmacokinetics ``` Read more ``` See why Profil is the perfect partner for pharmacokinetics studies. ](https://www.profil.com/services/pharmacokinetics?hsLang=en-us) [Bridging Studies ``` Read more ```  Discover the value of a Japanese bridging study. ](https://www.profil.com/services/bridging-study?hsLang=en-us) [Safety and Tolerability ``` Read more ``` Read about safety and tolerability studies at Profil. ](https://www.profil.com/services/safety?hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Linnebjerg, H. et al. 2020. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial. Clin Pharmacokinet. 2020 Dec;59(12):1589-1599.   [View all](https://www.profil.com/knowledge-center/publications?hsLang=en-us) The Profil Institute for Metabolic Research supports the **clinical development** of the full range of diabetes medication and instrumentation. Our services include clinical trials of antidiabetic drugs, insulin alternatives and personalized diabetes treatments and full support for insulin development. Clinical trials for diabetes drugs are possible thanks to our extensive experience with the methodologies necessary for this type of pharma development. We stand ready to act as pharmaceutical research associates to all institutions engages in diabetes treatment development. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=en-us) | [Privacy Policy](https://www.profil.com/privacy?hsLang=en-us)